Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion

Sanja Stevanović, Cornelis A. M. van Bergen, Simone A. P. van Luxemburg-Heijs, Boris van der Zouwen, Ekaterina S. Jordanova, Alwine B. Kruisselbrink, Marian van de Meent, Jessica C. Harskamp, Frans H. J. Claas, Erik W. A. Marijt, Jaap Jan Zwaginga, Constantijn J. M. Halkes, Inge Jedema, Marieke Griffioen, J. H. Frederik Falkenburg

Blood (2013) 122 (11): 1963–1973.

https://doi.org/10.1182/blood-2012-12-470872

Published: 2013

Includes: Supplemental data

Journal Articles

Quantitative Monitoring of NPM1A Mutations Can Be Used to Guide Immunotherapeutic Interventions After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Jessica C. Harskamp, MD, Joya E. Nahon, Andrea M. Siegel, Hans L. Vos, PhD, Piëette P. Deutz-Terlouw, J.Hendrik Veelken, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2011) 118 (21): 3061.

https://doi.org/10.1182/blood.V118.21.3061.3061

Published: 2011

Journal Articles

HLA Class II Upregulation During An Ongoing Viral Infection Can Lead to HLA-DP Directed Graft-Versus-Host Disease After HLA-DPB1 Mismatched CD4+ Donor Lymphocyte Infusion

Sanja Stevanovic, MSc, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Jessica C. Harskamp, MD, C.J.M. Halkes, MD, PhD, Marieke Griffioen, PhD, J.H. Frederik Falkenburg, MD, PhD

Blood (2011) 118 (21): 3062.

https://doi.org/10.1182/blood.V118.21.3062.3062

Published: 2011

Journal Articles

Eradication of Recipient CMV Specific T Cells by Donor Lymphocyte Infusion Does Not Impair Protective Immunity In Patients Transplanted with a CMV Negative Donor Due to An Early Donor Derived Primary CMV Specific T Cell Response

Pim L.J. van der Heiden, MD, Jessica C. Harskamp, Esther H.M. van Egmond, Piëtte P. Deutz-Terlouw, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2010) 116 (21): 834.

https://doi.org/10.1182/blood.V116.21.834.834

Published: 2010

Journal Articles

T Cell Chimerism After T Cell Depleted Allogeneic Stem Cell Transplantation Is Influenced by Immunological Factors Including the Conditioning Regimen, CMV Serostatus and GvHD and Does Significantly Bias Overall Chimerism Status

Jessica C. Harskamp, MD, Pim L.J. van der Heiden, MD, Esther H.M. van Egmond, Sabrina A.J. Veld, Hans L. Vos, PhD, Constantijn J.M. Halkes, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2010) 116 (21): 1321.

https://doi.org/10.1182/blood.V116.21.1321.1321

Published: 2010

Journal Articles

Myeloid Chimerism Reflects Engraftment of Donor Hematopoiesis, Whereas T Cell Chimerism Reflects Survival and Expansion of Donor and Recipient Residual Mature T Cells Early After T Cell Depleted Allogeneic Stem Cell Transplantation.

Jessica C. Harskamp, Esther H.M. van Egmond, Hans L. Vos, PhD, Stijn J.M. Halkes, MD, PhD, Roel Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2009) 114 (22): 4475.

https://doi.org/10.1182/blood.V114.22.4475.4475

Published: 2009

NARROW

HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion

Quantitative Monitoring of NPM1A Mutations Can Be Used to Guide Immunotherapeutic Interventions After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

HLA Class II Upregulation During An Ongoing Viral Infection Can Lead to HLA-DP Directed Graft-Versus-Host Disease After HLA-DPB1 Mismatched CD4+ Donor Lymphocyte Infusion

Eradication of Recipient CMV Specific T Cells by Donor Lymphocyte Infusion Does Not Impair Protective Immunity In Patients Transplanted with a CMV Negative Donor Due to An Early Donor Derived Primary CMV Specific T Cell Response

T Cell Chimerism After T Cell Depleted Allogeneic Stem Cell Transplantation Is Influenced by Immunological Factors Including the Conditioning Regimen, CMV Serostatus and GvHD and Does Significantly Bias Overall Chimerism Status

Myeloid Chimerism Reflects Engraftment of Donor Hematopoiesis, Whereas T Cell Chimerism Reflects Survival and Expansion of Donor and Recipient Residual Mature T Cells Early After T Cell Depleted Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion

Quantitative Monitoring of NPM1A Mutations Can Be Used to Guide Immunotherapeutic Interventions After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

HLA Class II Upregulation During An Ongoing Viral Infection Can Lead to HLA-DP Directed Graft-Versus-Host Disease After HLA-DPB1 Mismatched CD4+ Donor Lymphocyte Infusion

Eradication of Recipient CMV Specific T Cells by Donor Lymphocyte Infusion Does Not Impair Protective Immunity In Patients Transplanted with a CMV Negative Donor Due to An Early Donor Derived Primary CMV Specific T Cell Response

T Cell Chimerism After T Cell Depleted Allogeneic Stem Cell Transplantation Is Influenced by Immunological Factors Including the Conditioning Regimen, CMV Serostatus and GvHD and Does Significantly Bias Overall Chimerism Status

Myeloid Chimerism Reflects Engraftment of Donor Hematopoiesis, Whereas T Cell Chimerism Reflects Survival and Expansion of Donor and Recipient Residual Mature T Cells Early After T Cell Depleted Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only